Dental Biomaterials Market Growth & Trends
The global dental biomaterials market size is expected to reach USD 12.3 billion by 2027, expanding at a CAGR of 6.2%, according to a new report by Grand View Research, Inc. Rising prevalence of tooth disorder is one of the major factors contributing to market growth. Dental biomaterials include biocompatible synthetic materials and natural tissues to restore tooth decay, damage, and fractures problems. As the geriatric population worldwide affected by tooth decay is huge despite significant advances in tooth restoration and caries prevention, the rising incidence of tooth disorder continues to pose a considerable burden to healthcare. In such cases, biological materials play an important role in the restoration of the damaged tooth structure.
Also, increasing dental tourism and rising disposable income in developing countries are some of the major factors responsible for market growth during the assessment period. Further, due to the rising penetration of tooth implants, various companies are shifting their focus on research and development of dental biological materials. Also, the growing geriatric population and development in the field are some of the major factors contributing to the growth of the market.
North America dominated the market and accounted for about 36.0% of the market share in 2019. Growing government expenditure on oral health and increasing adoption of dental biological materials to produce implants is expected to be one of the major factors contributing to market growth in this region.
Whereas, Asia Pacific is anticipated to witness rapid growth during the forecast period due to improved regulatory framework, and an increase in the number of hospitals and clinics dealing in tooth disorders. This can be attributed to increased opportunities for players, especially in Japan, China, and India.
Request For Free Sample Report @ www.grandviewresearch.com/industry-analysis/dental-biomaterials-market/request/rs1
Dental Biomaterials Market Report Highlights
- The ceramic biomaterial segment dominated the market with revenue share of 36.0% in 2019 due to the rising penetration of tooth implants and the increasing use of ceramic biological material in dentistry
- The composite biomaterials segment is anticipated to witness the highest CAGR of 6.7% over the forecast period due to recent technological development
- North America dominated the market in 2019. Growing government expenditure on oral health is one of the major factors driving the market in the region
- In Asia Pacific, the market is projected to witness the fastest growth during the forecast period owing to the increasing incidence of tooth disorder in the region.
Dental Biomaterials Market Segmentation
Grand View Research has segmented the global dental biomaterials market based on type, application, end use, and region:
Dental Biomaterials Type Outlook (Revenue, USD Million, 2016 – 2027)
Dental Biomaterials Application Outlook (Revenue, USD Million, 2016 – 2027)
Dental Biomaterials End-use Outlook (Revenue, USD Million, 2016 – 2027)
- Dental Hospitals and Clinics
- Dental Laboratories
- Dental Academies and Research Institutes
- Dental Product Manufacturers
Dental Biomaterials Regional Outlook (Revenue, USD Million, 2016 – 2027)
- North America
- Asia Pacific
- South Korea
- New Zealand
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
List of Key Players of Dental Biomaterials Market
- Straumann Holding AG
- Geistlich Pharma AG
- Zimmer Biomet Holdings, Inc.
- Danaher Corporation
- Dentsply Sirona, Inc.
- 3M Company
- Royal DSM
- Carpenter Technology Corporation
- Kuraray Co., Ltd.
- Medtronic PLC
- Henry Schein, Inc.
- Mitsui Chemicals, Inc.
- Victrex PLC
- Ivoclar Vivadent AG
- GC Corporation
Browse Related Reports :
Dental Fluoride Treatment Market Size, Share & Trends Analysis Report By Product (Varnish, Toothpaste, Mouth Rinse, Gel, Supplements, Others), By Region, And Segment Forecasts, 2020 – 2027
Transplantation Market Size, Share & Trends Analysis Report By Product Type (Tissue Products, Immunosuppressive Drugs), By Application Type (Organ, Tissue Transplants), By End Use, And Segment Forecasts, 2020 – 2027
Dental Biomaterials Market Report Scope
|Market size value in 2020||USD 8.0 billion|
|Forecast value in 2027||USD 12.3 billion|
|Growth rate||CAGR of 6.2% from 2020 to 2027|
|Base year for estimation||2019|
|Historical data||2016 – 2018|
|Forecast period||2020 – 2027|
|Quantitative units||Revenue in USD Million and CAGR from 2020 to 2027|
|Report coverage||Revenue forecast, company share, competitive landscape, growth factors and trends|
|Segments covered||Type, application, end use, region|
|Regional scope||North America; Europe; Asia Pacific; Latin America; Middle East & Africa|
|Country scope||U.S.; Canada; U.K.; Germany; France; Italy; Spain; Netherlands; Belgium; Switzerland; Russia; Sweden; China; India; Japan; Australia; South Korea; Malaysia; Indonesia; Singapore; Philippines; Thailand; Mexico; Brazil; Argentina; Colombia; Chile; South Africa; Saudi Arabia; UAE; Israel; Egypt|
|Key companies profiled||Straumann Holding AG; Geistlich Pharma AG; Zimmer Biomet Holdings, Inc.; Danaher Corporation; Dentsply Sirona, Inc.; 3M Company; Royal DSM; Carpenter Technology Corporation; Kuraray Co., Ltd.; Medtronic PLC; Henry Schein, Inc.; Mitsui Chemicals, Inc.; Victrex PLC; Ivoclar Vivadent AG; GC Corporation|
|Customization scope||Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.|
|Pricing and purchase options||Avail customized purchase options to meet your exact research needs. Explore purchase options|
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
Country: United States